Mouse growth hormone secretagogue receptor
CA 2335272 A1 · Owner: Van Der Ploeg, Leonardus H. T. · Inventors: Jiang, Michael M.; Howard, Andrew D.; Zheng, Hui
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A mouse growth hormone secretagogue receptor has been isolated cloned and , sequenced. This receptor is characteristic of the G-protein family of receptors. Mouse growth hormone secretagogue receptors may be used to screen and identify compounds which bind to the mouse growth hormone secretagogue receptor. Such compounds may be used in the treatment of conditions which occur when there is a shortage of growth hormone such as observed in growth , hormone deficient children elderly patients with musculoskeletal impairment and those recovering from hip fracture and osteoporosis. Targeted disruption of the mouse GHS-R gene may prove useful in elucidation of the mechanism of action and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 8, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 8, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 8, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.